Showing results (61-70 of 86) with videos related to

Sort By:
Pageof 9
Trials|May 18, 2022
INNODIA Master Protocol for the evaluation of investigational medicinal products in children, adolescents and adults with newly diagnosed type 1 diabetesDavid B Dunger, Sylvaine F A Bruggraber, Adrian P Mander, et al.
British Journal of Clinical Pharmacology|July 15, 2023
Phase 1 safety, tolerability, pharmacokinetics and pharmacodynamic results of KCL-286, a novel retinoic acid receptor-β agonist for treatment of spinal cord injury, in male healthy participantsMaria B Goncalves, Tim Mant, Jörg Täubel, et al.
The American Journal of Clinical Nutrition|August 31, 2012
Incorporation of eicosapentaenoic and docosahexaenoic acids into lipid pools when given as supplements providing doses equivalent to typical intakes of oily fishLucy M Browning, Celia G Walker, Adrian P Mander, et al.
Kidney International|August 21, 2014
A systematic review and meta-analysis indicates underreporting of renal dysfunction following endovascular aneurysm repairAlan Karthikesalingam, Sandeep S Bahia, Shaneel R Patel, et al.
The American Journal of Clinical Nutrition|April 7, 2007
Use of stable-isotope techniques to validate infant feeding practices reported by Bangladeshi women receiving breastfeeding counselingSophie E Moore, Andrew M Prentice, W Andy Coward, et al.
The Journal of Clinical Endocrinology and Metabolism|June 4, 2018
Frequent Monitoring of C-Peptide Levels in Newly Diagnosed Type 1 Subjects Using Dried Blood Spots Collected at HomeRuben H Willemsen, Keith Burling, Peter Barker, et al.
Genes & Nutrition|February 22, 2012
Genetic predisposition to type 2 diabetes is associated with impaired insulin secretion but does not modify insulin resistance or secretion in response to an intervention to lower dietary saturated fatCelia G Walker, Ruth J F Loos, Adrian P Mander, et al.
BMC Public Health|June 20, 2014
Weight loss referrals for adults in primary care (WRAP): protocol for a multi-centre randomised controlled trial comparing the clinical and cost-effectiveness of primary care referral to a commercial weight loss provider for 12 weeks, referral for 52 weeks, and a brief self-help intervention [ISRCTN82857232]Amy L Ahern, Paul N Aveyard, Jason Cg Halford, et al.
BMC Medical Research Methodology|January 20, 2019
How to design a dose-finding study using the continual reassessment methodGraham M Wheeler, Adrian P Mander, Alun Bedding, et al.
European Journal of Cancer (Oxford, England : 1990)|August 31, 2010
A phase 2 study of vatalanib in metastatic melanoma patientsNatalie Cook, Bristi Basu, Swethajit Biswas, et al.
Pageof 9